Jaguar Health
JAGX
6 hedge funds and large institutions have $61.4K invested in Jaguar Health in 2025 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 0 closing their positions.
100% more funds holding
Funds holding: 3 → 6 (+3)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
72% less capital invested
Capital invested by funds: $223K → $61.4K (-$162K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$38.6K |
| 2 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$20.1K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$10K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$772 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DS
DRW Securities
Chicago,
Illinois
|
-$119K |
| 2 |
Morgan Stanley
New York
|
-$23 |
JAGX Hedge Fund Activity: Q4 2025 in Review
6 of the 8,282 institutional investors tracked by Wall St. Rank reported a position in Jaguar Health (JAGX) for Q4 2025, worth a combined $61.4K — down 72% from $223K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new JAGX positions and 0 closed out — a net gain of 3 holders — while 1 added to existing stakes and 1 trimmed.
The largest buyer was Geode Capital Management, opening a new position worth an estimated $38.6K. The largest seller was DRW Securities, cutting an estimated $119K.
- 6 institutional investors held Jaguar Health (JAGX) as of Q4 2025, up from 3 in Q3 2025.
- Funds reported $61.4K of Jaguar Health stock for Q4 2025, down 72% quarter-over-quarter.
- 3 funds opened new Jaguar Health positions in Q4 2025 and 0 closed out, a net change of +3 holders.
- The largest Jaguar Health buyer in Q4 2025 was Geode Capital Management, an estimated $38.6K added.
- The largest Jaguar Health seller in Q4 2025 was DRW Securities, an estimated $119K sold.
Based on aggregated 13F filings for Q4 2025.